Last reviewed · How we verify

NCT03895060

Vertical and Horizontal Alveolar Ridge Augmentation Using Autogenous Onlay Blocks Combined With Guided Bone Regeneration Using Native Collagen Membrane in Atrophic Anterior Maxilla.

Status unknown NA Last updated 29 March 2019
What this trial tests

NA trial testing autogenous ring blockls with GBR covered by collagen membrane in Anterior Maxilla With Deficient Ridge Height and/or Width in 10 participants. Status unknown.

Timeline
1 April 2019
Primary endpoint
1 March 2020
30 March 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 April 2019
Primary completion1 March 2020
Estimated completion30 March 2020

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 60, any sex, with Anterior Maxilla With Deficient Ridge Height and/or Width. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many different techniques exist for effective vertical bone augmentation, such as the use of particulate bone grafts and bone graft substitutes, barrier membranes for guided bone regeneration (GBR), autogenous and allogenic block grafts, and the application of distraction osteogenesis. Harvesting of autogenous block grafts is associated with greater morbidity compared with the less invasive procedure of using autogenous particles harvested through bone scrapers. On the other hand, particulate grafts always require a space-maintaining barrier, or their physical properties would not allow three-dimensional bone regeneration as those of block grafts do.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing